top of page
Spring Banner.jpg

Spring 2023 MIT Webconference

June 7 - 8 

The Longwood Healthcare Leaders Spring MIT Webconference is co-hosted by Nobelist Phil Sharp and centered on MIT’s Koch Institute via ZOOM with top biopharma CEOs, heads of R&D, life science investors, and leading researchers in an off-the-record setting. 

 

Registered participants are invited to join a cocktail reception in Boston at the close of the meeting, June 8, 5 –7 pm.

Featured Speakers

Featured Speakers
Agenda

Longwood Healthcare Leaders Spring Webconference

June 7-8, 2023

Agenda

Day 1
Spring Banner (3).jpg

7:30 am ET

LONGWOOD FUND INTRODUCTION

Christoph WestphalGeneral Partner, Longwood Fund

 

8:00 am ET

NEWCO: SHAPING THE NARRATIVE

 

8:30 am ET

BIG BIOPHARMA R&D

Glenn Gormley, Head, R&D; Executive Chair & President, Daiichi Sankyo

Sek Kathiresan, CEO, Verve Therapeutics

 

9:00 am ET

REGULATORY KEYNOTE

Peter Marks, Director, Center for Biologics Evaluation and Research, FDA

 

9:20 am ET

SPOTLIGHT ON MIT INNOVATION

Angie Belcher, Head of the Department of Biological Engineering, MIT

Sangeeta Bhatia, Director, Marble Center for Cancer Nanomedicine, MIT

Paula Hammond, Institute Professor; Department Head, Chemical Engineering, MIT

Moderator: Jane Wilkinson, Executive Director, Koch Institute at MIT

 

9:50 am ET

INNOVATION IN THE ERA OF IRA

 

10:20 am ET

ACCELERATING THE PATH TO PATIENT CARE

Arpa Garay, Chief Commercial Officer, Moderna

Richard Paulson, CEO, Karyopharm

David Weinreich, EVP, Head, Global Clinical Development; Co-Head, Global Development, Regeneron

 

10:50 am ET

FIRESIDE CHAT

 

11:10 am ET

EXPLOSION OF MODALITIES

John Lepore, SVP, Head, Research, GlaxoSmithKline

Jim List, Global TA Head, CV, Metabolism, Retina & Pulmonary Hypertension, Janssen R&D

Anabella Villalobos, SVP, Biotherapeutics & Medicinal Sciences, Biogen

 

11:40 am ET

TIMING THE IPO

 

12:10 pm ET

NOVEL APPROACHES TO DRUG DISCOVERY

Alise Reicin, CEO, Tectonic Therapeutics

Kathy Seidl, Head, Oncology Drug Discovery, Takeda

 

12:40 pm ET

CULTIVATING AN ECOSYSTEM OF PARTNERS

John Flavin, Chair, Pyxis Oncology

John Glasspool, CEO, Anthos Therapeutics

Heather Schwoebel, COO & CBO, Alloy Therapeutics

Ramona Sequeira, President, Global Portfolio, Takeda

 

1:10 pm ET

MOVING FROM TREATMENT TO CURE

Kara Carter, EIR, Evotec

 

1:30 pm ET

FIRESIDE CHAT

 

1:50 pm ET

TRANSFERRING TECHNOLOGY FROM ACADEMIA

Phil Johnson, CEO, Interius

 

2:20 pm ET

EARLY PREPARATION FOR PARTNERING

Stu Mackey, Global Head, BD, Daiichi Sankyo

Amanda Wagner, CEO, Immunitas

 

2:50 pm ET

PREPARING FOR THE FUTURE OF R&D

Fabrice Chouraqui, CEO, Cellarity

Lloyd Minor, Dean, Stanford Medicine

Zhen Su, CEO, Marengo Therapeutics

 

3:20 pm ET

FIRESIDE CHAT

 

3:40 pm ET

ACCELERATING DRUG DEVELOPMENT

Anirvan Ghosh, CEO, Unity Biotechnology

 

4:10 pm ET

CONVENING A STRONG SYNDICATE

Ansbert Gadicke, Managing Director, MPM Capital

 

4:40 pm ET

LONGWOOD FUND UPDATE                                         

Spring Banner (2).png

Wednesday Agenda

Spring Banner (1).jpg

Thursday Agenda

7:30 am ET

LONGWOOD FUND INTRODUCTION

David SteinbergGeneral Partner, Longwood Fund

 

8:00 am ET

PORTFOLIO COMPANY PRESENTATION

 

8:20 am ET

BIG BIOPHARMA PIPELINE SOURCING

David Loew, CEO, Ipsen

John Reed, EVP, Global Head, R&D, Sanofi

 

8:50 am ET

CROSS-BORDER COLLABORATION

Rachna Khosla, SVP, BD, Amgen

Neil Warma, CEO, Genexine

 

9:20 am ET

DATA SCIENCE EVOLUTION & ENABLEMENT

 

9:50 am ET

FIRESIDE CHAT

Phil Sharp, Institute Professor, MIT; Nobel Laureate & Co-Founder, Alnylam/Biogen

 

10:10 am ET

ADVANCES IN CLINICAL TRIALS

Maria Maccecchini, CEO, Annovis Bio

 

10:40 am ET

MAXIMIZING PLATFORM POTENTIAL

Guillaume Pfefer, CEO, Senda Biosciences

 

11:10 am ET

ADVANCES IN NEUROSCIENCE

Saul Kato, CEO, Herophilus

 

11:40 am ET

FIRESIDE CHAT

 

12:00 pm ET

LIFE SCIENCE MARKET OUTLOOK

Rahul Kakkar, Entrepreneur-Partner, Polaris

 

12:30 pm ET

R&D COLLABORATION

Bill Mezzanotte, Head, R&D & CMO, CSL

 

1:00 pm ET

ALIGNING PRIORITIES WITH THE BOARD

Al Gianchetti, CEO, XyloCor Therapeutics

John McCabe, CFO & COO, DEM Biopharma

 

1:30 pm ET

IMPLEMENTING A FOUNDATIONAL PARTNERING STRATEGY

Krishnan Viswanadhan, COO, Be Bio

 

2:00 pm ET

FIRESIDE CHAT: 340B DRUG PRICING & REFORMS

Alexander Hardy, CEO, Genentech

 

2:20 pm ET

OPTIMIZING THE PIPELINE

José Trevejo, CMO, Tarsus

 

2:50 pm ET

SOURCING AND IDENTIFYING NOVEL TECHNOLOGY

Michal Preminger, Head, Innovation, Johnson & Johnson, East North America

 

3:20 pm ET

FIRESIDE CHAT

Andy Plump, President, R&D, Takeda

Rupert Vessey, President, Research & Early Development, Bristol Myers Squibb

 

3:40 pm ET

NAVIGATING REGULATORY CHALLENGES

Rachelle Jacques, CEO, Akari

Eliezer Katz, CMO, eGenesis

                                                                                               

4:10 pm ET

FINANCING INNOVATION

Karin Kleinhans, Partner, MRL Ventures Fund

 

4:40 pm ET

LONGWOOD FUND UPDATE

 

Spring Banner (4).png
Day 2
Spring Banner (2).png

Thursday, June 8, 2023 

5:00pm - 7:00pm

Registered participants are invited to join a cocktail reception at MIT’s Koch Institute at the close of the meeting.

Cocktail Reception

Cocktail Reception
Register

These meetings are focused on accelerating the translation of discoveries into medicines to help patients; donations enabled by these meetings benefit The Boston Foundation, BSO, Harvard Medical School, MIT, Life Science Cares, and other charities. 

Spring Banner (1).jpg
To learn more about getting involved contact sg@longwoodfund.com

Supporters

Untitled design (3).png
ZS_Logo_RGB_4x.png
Spring Banner (1).jpg
Supporters
Klick logo.jpg
ARE_RGB_Stacked_Tagline_300dpi.jpg
bottom of page